The day it hit th 0.035c high it also had almost 50% higher volume too, I believe 80% of which traded up the other 20 traded it back down (roughly)
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
The day it hit th 0.035c high it also had almost 50% higher volume too, I believe 80% of which traded up the other 20 traded it back down (roughly) 
